Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with β-glucans from oats or barley: A randomised dose-controlled trial

European Journal of Clinical Nutrition

Volumn 59, Issue 11, 2005, Pages 1272-1281

  Biorklund M ^a   van Rees, A ^b   Mensink, R P ^b   Önning, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

glucan; Barley; Glucose; Insulin; LDL cholesterol; Oats

Indexed keywords

BETA GLUCAN; CHOLESTEROL; GLUCOSE; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BARLEY; BEVERAGE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH CARE FACILITY; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OAT; PARALLEL DESIGN; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; AVENA SATIVA; BETA-GLUCANS; BEVERAGES; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD, FORTIFIED; HORDEUM; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN; LIPIDS; MALE; MIDDLE AGED; NETHERLANDS; PHYTOTHERAPY; POSTPRANDIAL PERIOD; SINGLE-BLIND METHOD; SWEDEN;

AVENA; HORDEUM VULGARE SUBSP. VULGARE;

EID: 27844510122     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602240     Document Type: Article

References (31)

1. Åman P, Rimsten L & Andersson R (2004): Molecular weight distribution of β-glucan in oat-based foods. Cereal Chem. 81, 356-360.
2. Amundsen ÅL, Haugum B & Andersson H (2003): Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand. J. Nutr. 47, 68-74.
3. Anderson JW, Spencer DB, Hamilton CC, Smith SF, Tietyen J, Bryant CA & Oeltgen P (1990): Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am. J. Clin. Nutr. 52, 495-499.
4. Anon (1989): AACC committee adopts oat bran definition. Cereal Foods World 34, 1033.
5. Asp NG, Mattsson B & Önning G (1991): Variation in dietary fibre, β-glucan, starch, protein, fat and hull content of oats grown in Sweden 1987-1989. Eur. J. Clin. Nutr. 46, 31-37.
6. Behall KM, Scholfield DJ & Hallfrisch J (2004a): Lipids significantly reduced by diets containing barley in moderately hypercholesterolemic men. J. Am. Coll. Nutr. 23, 55-62.
7. Behall KM, Scholfield DJ & Hallfrisch J (2004b): Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. J. Am. Clin. Nutr. 80, 1185-1193.
8. Bourdon I, Yokoyama W, Davis P, Hudson C, Backus R, Richter D, Knuckles B & Schneeman BO (1999): Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with β-glucan. Am. J. Clin. Nutr. 69, 55-63.
9. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P & Collins MW (1994): Oat β-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur. J. Clin. Nutr. 48, 465-474.
10. Davidson MH, Dugan LD, Burns JH, Bova J, Story K & Drennan KB (1991): The hypocholesterolemic effects of β-glucan in oatmeal and oat bran. A dose controlled study. JAMA 265, 1833-1839.
11. De Groot AP, Luyken R & Pikaar NA (1963): Cholesterol-lowering effect of rolled oats. Lancet 2, 303-304.
12. Dubois C, Armand M, Senft M, Portugal H, Pauli AM, Bernard PM, Lafont H & Lairon D (1995): Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults. Am. J. Clin. Nutr. 61, 325-333.
13. Food and DHug Administration (1997): Food labelling: health claims; soluble fibre from whole oats and risk of coronary heart disease. Fed. Regist. 62, 15343-15344. Internet: http://www.cfsan.fda.gov/~lrd/ fr970331.html.
14. Friedewald WT, Levy RI & Fredrickson DS (1972): Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1, 499-502.
15. Hallfrisch J & Behall KM (2000): Mechanism of the effects of grains on insulin and glucose responses. J. Am. Coll. Nutr. 19 (Suppl 3), S320-S325.
16. Keogh GF, Garth JSC, Mulvey TB, McArdle BH, Coles GD, Monro JA & Poppitt SD (2003): Randomized crossover study of the effect of a highly β-glucan enriched barley on CVD risk factors in mildly hypercholesterolemic men. Am. J. Clin. Nutr. 78, 711-718.
17. Kerckhoffs DA, Hornstra G & Mensink RP (2003): Cholesterol-lowering effect of β-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when β-glucan is incorporated into bread and cookies. Am. J. Clin. Nutr. 78, 221-227.
18. Lambo AM, Öste R & Nyman M (2005): Dietary fibre in fermented oat and barley β-glucan rich concentrates. Food Chem. 89, 283-293.
19. Lia Å, Hallmans G, Sandberg A-S, Sundberg B, Åman P & Andersson H (1995): Oat β-glucan increases bile acid excretion and a fibre-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am. J. Clin. Nutr. 62, 1245-1251.
20. Liljeberg HG, Granfeldt YE & Björck IM (1996): Products based on high fibre barley genotype, but not on common barley or oats, lower postprandial glucose and insulin repones in healthy humans. J. Nutr. 126, 458-466.
21. Lovegrove JA, Clohessy A, Milon H & Williams CM (2000): Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am. J. Clin. Nutr. 72, 49-55.
22. Mälkki Y, Autio K & Hanninen O (1992): Oat bran concentrates: physical properties of β-glucan and hypocholesterolemic effects in rats. Cereal Chem. 69, 647-653.
23. McIntosh GH, Whyte J, McArthur R & Nestel P (1991): Barley and wheat foods: Influence on plasma cholesterol concentrations in hypercholesterolemic men. Am. J. Clin. Nutr. 53, 1205-1209.
24. Mensink RP, Zock PL, DM Kester A & Katan MB (2003): Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146-1155.
25. Önning G (2004): The use of cereal β-glucan to control diabetes and cardiovascular disease. In Functional Foods, Cardiovascular Disease and Diabetes ed. A Arnoldi, pp 402-421. Cambridge, England: Woodhead Publishing Ltd.
26. Önning G, Wallmark A, Persson M, Åkesson B, Elmstahl S & Öste R (1999): Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann. Nutr. Metab. 43, 301-309.
27. Oscarsson M, Andersson R, Åman P, Olofsson S & Jonsson A (1998): Effects of cultivar, nitrogen ferilization rate and environment on yield and grain quality of barley. J. Sci. Food Agric. 78, 359-366.
28. Poulter N, Chang CL, Cuff A, Poulter C, Sever P & Thom S (1994): Lipid profiles after the daily consumption of an oat-based cereal: A controlled crossover trial. Am. J. Clin. Nutr. 59, 66-69.
29. Ripsin CM, Keenan JM, Jacobs Jr DR, Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, Hegsted M, Davidson DM, Davidson MH, Dugan LD, Demark-Wahnefried W & Beling S (1992): Oat products and lipid lowering. A meta-analysis. JAMA 267, 3317-3325.
30. Törronen R, Kansanen L, Uusitupa M, Hanninen O, Myllymaki O, Harkonen H & Mälkki Y (1992): Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur. J. Clin. Nutr. 46, 621-627.
31. Whyte JL, McArthur R, Topping D & Nestel P (1992): Oat bran lowers plasma cholesterol concentrations in mildly hypercholesterolemic men. J. Am. Diet. Assoc. 92, 446-449.